Intravesical BCG administration in the guinea pig
- 1 December 1992
- journal article
- research article
- Published by Springer Nature in Virchows Archiv B Cell Pathology Including Molecular Pathology
- Vol. 61 (1) , 159-167
- https://doi.org/10.1007/bf02890418
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Bacillus Calmette‐Guéarin‐treated superficial bladder cancer: Correlation of morphology with immunophenotypingThe Journal of Pathology, 1990
- Presence of interleukin-2 in urine of superficial bladder cancer patients after intravesical treatment with bacillus Calmette-GuérinCancer Immunology, Immunotherapy, 1990
- HLA—DR Expression by High Grade Superficial Bladder Cancer Treated with BCGBritish Journal of Urology, 1989
- Flow Cytometric Analysis of Lymphocyte Populations in Guinea Pig Blood and SpleenInternational Archives of Allergy and Immunology, 1988
- Local Immune Responses after Intravesical BCG Treatment for Carcinoma in situBritish Journal of Urology, 1987
- Functionally relevant membrane proteins of human and guinea-pig T lymphocytesMolecular Immunology, 1986
- Interleukin-2 production during intravesical bacille Calmette-Guerin therapy for bladder cancerClinical Immunology and Immunopathology, 1986
- MHC‐Restricted T Cell Activation: Analysis with T Cell HybridomasImmunological Reviews, 1983
- Monoclonal antibodies to guinea pig Ia antigens. II. Effect on alloantigen-, antigen-, and mitogen-induced T lymphocyte proliferation in vitro.The Journal of Experimental Medicine, 1980
- Modulation of immunity by bacillus calmette-guérin (BCG)Pharmacology & Therapeutics, 1979